Respiratory Technologies Inc.
Industry
- Medical Devices
See more in Biomedtracker
Latest on Respiratory Technologies Inc.
In Vivo
• By Amanda Micklus and Maureen Riordan
Device Transactions Continuing the downward trend in financing over the past several quarters, the device industry collected $1.2 billion in Q2 funding, a 48% decrease from Q1's $2.3 billion total. It
Medtech Insight
• By Catherine Longworth
[ Editors' note : For more details about M&A deals in 2017 and previous years, go to Medtech Insight's M&A deal tracker: https://medtech.pharmamedtechbi.com/datasets/mna ] May proved to be a robust
In Vivo
• By Beth Allan, Deanna Kamienski, and Maureen Riordan
IN VITRO DIAGNOSTICS Financings Accelerate Diagnostics Inc. Infectious disease-focused Accelerate Diagnostics Inc. netted $74.6mm through the upsized follow-on offering of 2.75mm common shares pri